US 10745397
1-Substituted 1,2,3,4-tetrahydro-1,7-naphthyridin-8-amine derivatives and their use as EP4 receptor antagonists
granted A61PA61P19/02
Quick answer
US patent 10745397 (1-Substituted 1,2,3,4-tetrahydro-1,7-naphthyridin-8-amine derivatives and their use as EP4 receptor antagonists) held by Takeda Pharmaceutical Company Limited expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Aug 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61P, A61P19/02